Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,86116,880 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma
NATIONAL CANCER INSTITUTE Loyola Marymount University United States 2021 – 2025

Project Summary Given advances in screening and treatment, the number of people in the U.S. living with lung cancer is expected to increase by 25% (from 571,340 to 724,610) by 2030...

$283.8K
USD
Completed OTHER RESEARCH-RELATED
Do Tumor-Immune Interactions Prime Systemic Tolerance of Triple-Negative Breast Cancer Brain Metastases?
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2025

PROJECT SUMMARY / ABSTRACT It is widely estimated that 90% of cancer-related deaths are caused by metastasis. This statistic underscores our inability to manage cancer once it diss...

$1.63M
USD
Active NON-SBIR/STTR RPGS
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2026

PROJECT SUMMARY Tumor heterogeneity is the main cause of resistance to current chemotherapy drugs as well as metastasis development, leading to patients' death. Within the sam...

$817.2K
USD
Active NON-SBIR/STTR RPGS
Improving the translational value of head and neck cancer patient-in-mouse models
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2026

Project Abstract: Patient-derived model systems are commonly used to study tumor biology and test novel treatments for head and neck cancer. These models are established using pati...

$736K
USD
Active NON-SBIR/STTR RPGS
Urine based circulating tumor DNA analysis
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

ABSTRACT Urine is an underappreciated source for systemic circulating tumor DNA in patients with non-genitourinary cancers. Based on recent data suggesting that blood-based HPV DNA...

$720.6K
USD
Completed NON-SBIR/STTR RPGS
Targeting the Circadian Rhythm in Glioblastoma Stem Cells (R01CA238662)
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2024

Glioblastomas rank among the most lethal of all human cancers. Current therapy includes maximal surgical resection, followed by combined radiotherapy and oral chemotherapy (temozol...

$5.29M
USD
Active OTHER RESEARCH-RELATED
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide. The development of targeted molecular therapies that inhibit m...

$2.09M
USD
Completed OTHER RESEARCH-RELATED
Investigating apoptotic priming as a determinant of sensitivity to leukemia-directed therapies
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Acute myeloid leukemia (AML) is a lethal blood cancer characterized by a clonal expansion of precursor blood- forming cells. Intensive chemotherapy has bee...

$2.55M
USD
Active NON-SBIR/STTR RPGS
Genetic dissection of oncogenic Kras signaling
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

ABSTRACT Lung cancer is a prevalent cancer type that leads to more deaths than the next four major cancer types combined. KRAS is one of the most frequent oncogenes in human lung c...

$4.28M
USD
Active NON-SBIR/STTR RPGS
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2026

ABSTRACT Acute myeloid leukemias (AMLs) are a genetically heterogeneous group of clonal hematopoietic disorders characterized by accumulation of immature non-lymphoid marrow progen...

$3.56M
USD
Active OTHER RESEARCH-RELATED
Targeting an unrecognized checkpoint on T cell function in tumors
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT A diverse accumulation of infiltrating immune cells is a prominent feature of nearly all cancers1. By directing the effector functions of cancer-killing T...

$2.46M
USD
Completed NON-SBIR/STTR RPGS
High-Throughput Screen for the Oncoprotein MYC
NATIONAL CANCER INSTITUTE Scripps Research Institute, The United States 2021 – 2025

ABSTRACT MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apop...

$4.06M
USD
Active OTHER RESEARCH-RELATED
Decision Support for Multigene Panel Testing and Family Risk Communication among Racially/Ethnically Diverse Young Breast Cancer Survivors
NATIONAL CANCER INSTITUTE Florida Atlantic University United States 2021 – 2026

Project Summary/Abstract: The introduction of multi-gene panel testing for hereditary breast and ovarian cancer (HBOC) syndrome has rapidly changed the clinical approach to genetic...

$1.55M
USD
Active OTHER RESEARCH-RELATED
Defining PARP Inhibitor Response and Resistance in Prostate Cancer
NATIONAL CANCER INSTITUTE University of California At Davis United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The objective of this K01 award is to promote the development of Dr. Alan Lombard into an independent prostate cancer researcher. The proposed project will...

$1.67M
USD
Active NON-SBIR/STTR RPGS
RNase H2 is a novel therapeutic target in triple negative breast cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

Project Summary Due to their hyperproliferative nature and intrinsic genomic instability, triple-negative breast cancer (TNBC) cells exhibit high levels of replication stress, whic...

$3.76M
USD
Active NON-SBIR/STTR RPGS
Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2021 – 2026

Abstract In recent years, the incidence of colorectal cancer (CRC) under the age of 50-years has increased significantly and population-based screening is currently not offered to...

$6.59M
USD
Completed OTHER RESEARCH-RELATED
Defining mechanisms of thalidomide analog resistance
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2021 – 2025

PROJECT SUMMARY Thalidomide and its analogs, lenalidomide and pomalidomide, have revolutionized the treatment of patients with multiple myeloma (MM) and other hematologic malignanc...

$2.67M
USD
Active NON-SBIR/STTR RPGS
Developing novel bispecific antibodies for cancer treatment
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

PROJECT SUMMARY The overall goal of this project is to improve activities of therapeutic antibodies against cancer metastasis through developing novel bispecific antibodies (BsAbs)...

$2.94M
USD
Active NON-SBIR/STTR RPGS
Enhancing the efficacy of androgen signaling inhibitors in prostate cancer
NATIONAL CANCER INSTITUTE University of Kentucky United States 2021 – 2026

Title: Enhancing the efficacy of androgen signaling inhibitors in prostate cancer Abstract It has been documented that androgen receptor (AR) signaling remains to play a critical r...

$4.85M
USD
Active NON-SBIR/STTR RPGS
THE ROLE OF SELENOPROTEIN SYNTHESIS PATHWAY IN ACUTE MYELOID LEUKEMIA
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

AML is the most common acute leukemia in adults, and it appears increasingly with age. Despite overall improvement in the treatment of leukemia, AML still carries a devastating pro...

$4.56M
USD